Intellectual Property Watch is an independent news source covering international IP law and policy

Explore its archives, which span from 2005-2019, with the menu above or the link below.

Antibiotic Resistance Is “Already Here” And Pipeline Is Dry, UK Health Minister Tells UN

ByWilliam New Jun 8, 2016
Antibiotic Resistance Is “Already Here” And Pipeline Is Dry, UK Health Minister Tells UN

NEW YORK — An estimated one million people may already die each year because they are resistant to all known antibiotics, and the number could reach 10 million per year and devastate the world economy by 2050 unless key steps…

USTR: IPRs Among “Most Challenging” Issues As TPP Talks Accelerate

ByWilliam New Mar 14, 2013

Intellectual property rights are among the three “most challenging” issues still to be resolved in the Trans-Pacific Partnership (TPP) agreement negotiations following the latest round that wrapped up yesterday, the Office of the United States Trade Representative (USTR) has said.…

The World Is Going Flat(-Rate)

A new study shows a copyright exception for legalising file-sharing is feasible, as a cease-fire in the “war on copying” emerges. A new social contract between creatives and society is needed, says media sociologist Volker Grassmuck.

WHA Agrees On Drafting Of Roadmap For Access To Medicines And Vaccines; US Blasts Compulsory Licences

ByCatherine Saez May 24, 2018
WHA Agrees On Drafting Of Roadmap For Access To Medicines And Vaccines; US Blasts Compulsory Licences

The World Health Assembly yesterday agreed on a roadmap to be designed by the World Health Organization in consultation with member states to facilitate access to medicines and vaccines, including actions and activities for the period 2019-2023. If everyone agrees…

Special Report – Students To Universities: “We Have A Drug Problem”

ByJulia Fraser May 13, 2014

BASEL — Students from around the world are gathering momentum to challenge their universities’ licensing policies and research and development systems. That was one of the messages emerging from the annual meeting of Universities Allied for Essential Medicines (UAEM) Europe.